Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
6.17
-0.03 (-0.48%)
At close: Feb 13, 2026, 4:00 PM EST
6.19
+0.02 (0.32%)
After-hours: Feb 13, 2026, 4:00 PM EST
Inventiva Market Cap
Inventiva has a market cap or net worth of $1.2 billion as of February 13, 2026. Its market cap has increased by 419.71% in one year.
Market Cap
1.20B
Enterprise Value
1.21B
1-Year Change
419.71%
Ranking
Category
Stock Price
$6.17
Market Cap Chart
Since October 26, 2018, Inventiva's market cap has increased from $151.00M to $1.20B, an increase of 694.26%. That is a compound annual growth rate of 32.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.19B | 34.50% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immatics | 1.31B |
| DBV Technologies | 1.31B |
| Taysha Gene Therapies | 1.28B |
| Inhibrx Biosciences | 1.21B |
| Capricor Therapeutics | 1.21B |
| Septerna | 1.16B |
| Nanobiotix | 1.15B |
| Xeris Biopharma Holdings | 1.14B |